2020 journal article

Biomass of the Cyanobacterium Lyngbya wollei Alters Copper Algaecide Exposure and Risks to a Non-target Organism

BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, 104, 228–234.

author keywords: Copper; Cyanobacteria; Algaecide; Lyngbya wollei; Management
MeSH headings : Animals; Biodegradation, Environmental; Biomass; Copper / metabolism; Copper / toxicity; Cyanobacteria / metabolism; Daphnia / metabolism; Environmental Exposure / adverse effects; Environmental Exposure / prevention & control; Herbicides / metabolism; Herbicides / toxicity; Water Pollutants, Chemical / metabolism; Water Pollutants, Chemical / toxicity
TL;DR: Risks associated with a commonly applied chelated copper algaecide to a sentinel non-target species and alteration of the exposure and toxicity when a nuisance mat-forming cyanobacterium, Lyngbya wollei, was present in exposures are evaluated. (via Semantic Scholar)
UN Sustainable Development Goal Categories
13. Climate Action (Web of Science)
15. Life on Land (Web of Science)
Source: Web Of Science
Added: December 9, 2019

Nuisance algal infestations are increasing globally in distribution and frequency. Copper-based algaecides are routinely applied to control these infestations, though there is an ever-present concern of risks to non-target species. This research evaluated risks associated with a commonly applied chelated copper algaecide (Captain® XTR; SePRO Corporation) to a sentinel non-target species (Daphnia magna) and further assessed alteration of the exposure and toxicity when a nuisance mat-forming cyanobacterium, Lyngbya wollei, was present in exposures. Aqueous copper concentrations in treatments with algae significantly decreased within 1 h after treatment and averaged 57.5% of nominal amended Cu through the experiment duration. The 48 h LC 50 values were 371 µg Cu/L with no algae present in exposures and increased significantly to 531 µg Cu/L when L. wollei was simultaneously exposed. This research provides information on the short-term fate of copper and hazard assessment by incorporating targeted binding ligands, as present in operational treatments.